3 ms·
Supporters tout Ivermectin as Covid therapy, but skeptics call it 'the new HCQ'
- AndrewBissell 6y ago> A British trial called Recovery has provided important information about older drugs, finding that hydroxychloroquine did not help hospitalized covid-19 patients, while the steroid dexamethasone could be a lifesaver. But the United States has lagged behind in conducting such trials because of the fragmentation of the health-care system and the lack of financial incentive for pharmaceutical companies to continue to do research on old, cheap drugs. Good to know that financial incentives are the primary determinant around which trials are getting funded. Puts a different spin on things when people say repurposed drugs shouldn't be used because "there isn't enough evidence they help."